Responses to Colloid Infusions
Do 100 kiloDaltons Matter? A Prospective Randomised Double-blind Study on the Blood Volume Expanding Effects of Two Different Colloids in Patients Undergoing Laparoscopic Cholecystectomy
1 other identifier
interventional
24
1 country
1
Brief Summary
In situations such as dehydration, illness and surgery, fluid 'drips' are given to patients to keep them hydrated. Different fluids stay in the circulation for different lengths of time. For example, some types of fluid remain in the circulation for a short time which means patients would need to be given more fluid to achieve the desired effects. Giving a lot of fluid to sick patients can in itself cause problems, for example, it can affect the way the bowels work and delay the patient's recovery from illness. In these situations the investigators use specialized fluids called colloids, that are designed to stay in the circulation for longer. This means a smaller amount of fluid needs to be used and less problems are likely to occur. There are two different types of colloids that are commonly used, but the investigators do not know which of them is better. The purpose of this study is to investigate which of the two different colloids (one is called Gelofusin and the other is called Voluven) works better in patients who undergo surgery. Knowing which of the two fluids works best in patients will help us improve the care of surgical patients. The investigators hypothesis is that the fluid that has the larger size of molecules as part of the solution will work better during surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2009
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2009
CompletedFirst Posted
Study publicly available on registry
March 24, 2009
CompletedStudy Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedNovember 16, 2011
November 1, 2011
2.6 years
March 23, 2009
November 15, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The magnitude and duration of the plasma volume expanding effects of the two colloids.
4 hours
Secondary Outcomes (1)
To determine the effects of the two infusions on serum and urinary osmolality, sodium, potassium, chloride, bicarbonate, urea, albumin, microalbumin and haematological parameters.
4 hours
Study Arms (1)
1
EXPERIMENTALInterventions
1 litre infusion following induction of anaesthesia
Eligibility Criteria
You may qualify if:
- Male and female patients aged 18-60 years undergoing elective laparoscopic cholecystectomy for proven gallstone disease.
- BMI of 20-26 kg/m2
- Able to give voluntary written informed consent to participate in the study
- Able to understand the requirements of the study, including anonymous publication, and agree to co-operate with the study procedures
- (Females of child bearing age will be offered a pregnancy test)
You may not qualify if:
- Patients with a known history of allergic reaction to the colloid infusions
- Patients with acute cholecystitis or the systemic inflammatory response syndrome
- Patients with a serum bilirubin \> 25 μmol/l
- Females who are pregnant or refuse to have a pregnancy test
- Patients with a haemoglobin \< 10 g/l
- Patients with a history of acute pancreatitis
- Patients likely to undergo common bile duct exploration
- Patients with renal impairment, ischaemic heart disease, cardiac failure and chronic restrictive airways disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sherwood Forest Hospitals NHS Foundation Trust
Mansfield, Nottinghamshire, NG17 4JL, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Dileep Lobo, FRCS
University of Nottingham
- PRINCIPAL INVESTIGATOR
Mukul Dube, FRCS
Sherwood Forrest Hospitals NHS Trust
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2009
First Posted
March 24, 2009
Study Start
April 1, 2009
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
November 16, 2011
Record last verified: 2011-11